← Back to Clinical Trials
Recruiting NCT06476171

Validation of Hematological Indices

Trial Parameters

Condition Multiple Organ Dysfunction
Sponsor Petrovsky National Research Centre of Surgery
Study Type INTERVENTIONAL
Phase N/A
Enrollment 200
Sex ALL
Min Age 18 Years
Max Age 80 Years
Start Date 2023-06-19
Completion 2025-11-01
Interventions
Determination of the level of the studied biomarkers

Brief Summary

The hypothesis of the study is that hematological indices (neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and systemic index of inflammation) may be predictors of infectious complications and multiple organ dysfunction in patients after cardiac surgery.

Eligibility Criteria

Inclusion Criteria: * age from 18 to 80 years * cardiac surgery * operation in the conditions of cardiopulmonary bypass * availability of voluntary informed consent of the patient to participate in the study Exclusion Criteria: * refusal of the patient from the study * transfer of the patient to another medical institution

Related Trials